DALLAS, July 11, 2019 /PRNewswire/ -- New research from Parks Associates reveals 15% of US broadband households have used a te

SAN FRANCISCO, July 11, 2019 /PRNewswire/ -- Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued today by the Center for Medical Economics and Innovation at the California-based, free-market think ta

SOUTH SAN FRANCISCO, Calif., July 11, 2019 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a one-year Phase I Small Business Innovative Research (SBIR) grant for $225,000 in funding to Enable Biosciences to develop an improved Lyme disease te

JUPITER, Fla., July 11, 2019 /PRNewswire/ -- HeartCare Imaging, a leading provider of high-impact management solutions and diagnostic imaging services, has been selected by

EL SEGUNDO, Calif., July 11, 2019 /PRNewswire/ -- X Out®, a revolutionary prescription strength acne treatment line from the makers of Proactiv®, will be launching in GNC retailers throughout the United States beginning Summer 2019. This new line and retail partnership is aimed to tackle a void in the marketplace, giving young adu

TAMPA, Fla., July 11, 2019 /PRNewswire/ -- Keystone Heart Ltd. today announced that it has signed a distribution agreement with Ireland-based Vasorum Ltd. for sales and marketing of their Celt ACD® Vascular Closure Device.  The Celt ACD®, is an arterial puncture closure device that has be

ROCKVILLE, Md., July 11, 2019 /PRNewswire/ -- Dr. Joseph Kravitz is prosthodontist who comprehensively diagnoses and treats the dental health needs of patient

NEW YORK, July 11, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical- stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases, including Alzheimer's disease ("AD") is announcing that Dr. Daniel L. Alkon, the Company's President and CSO, will be honored among the recipients of the Cure

BOONTON, N.J., July 11, 2019 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologi

ENGLEWOOD, Colo., July 11, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel therapy aimed at treating common inflammatory conditions for which there are limited treatment